tourmaline – Talk Bio

Actionable Insights Powered by AI

Tourmaline Attracted Bidding War Before $1.4B Acquisition by Novartis

4 weeks ago talkbio0Tagged Acquisition, Antibodies, ASCVD, Bio, Cardiovascular Agents, interleukin-6, Novartis, pacibekitug, tourmaline

Tourmaline Bio; Novartis; acquisition; bidding war; $1.4 billion; pacibekitug; cardiovascular drug; IL-6 antibody; ASCVD; biotech

Tourmaline Bio’s Heart Drug Pacibekitug Shows Promise Against Cardiovascular Inflammation, Targets Competition with Novo, CSL

5 months ago talkbio0Tagged Cardiovascular system, heart drug, Inflammation, interleukin-6, Markers (device), Nordisk, pacibekitug, Phase 2 trial, SMPX gene, tourmaline, United States Food and Drug Administration

Tourmaline Bio; heart drug; pacibekitug; cardiovascular inflammation; inflammation markers; Novo Nordisk; CSL; Phase 2 trial; FDA; IL-6